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Abstract
Ji Hye Park1), Hyeon	Chang	Kim2)†, Ju-Mi	Lee2), Dong	Phil	Choi1), Bo	Mi	Song1),
Seung	Won	Lee1), Hansol	Choi1), Joo	Young	Lee2), Il	Suh2)
1)Department of Public Health, Yonsei University Graduate School
2)Department of Preventive Medicine, Yonsei University College of Medicine
Objectives: We investigated anthropometric measures of obesity, including body mass index (BMI), 
waist circumference (WC), and waist-to-height ratio (WHtR) in their associations with metabolic 
abnormalities in Korean adults.
Methods: Study participants were 1,399 male and 2,325 female community dwellers aged 40-79 years. 
Assessed metabolic variables included blood pressure, fasting glucose, insulin resistance, triglycerides, 
HDL cholesterol, LDL cholesterol, alanine aminotransferase, and gamma-glutamyl transferase. Associations 
of anthropometric measures per 1-SD increase with each metabolic abnormality were assessed using 
logistic regression analysis.  
Results: The adiposity measurements were significantly associated with all of the metabolic abnormalities, 
only except for with LDL cholesterol in men. In men, hypertension was more strongly associated withBMI 
(OR=1.58) than WC (OR=1.40) or WHtR (OR=1.44) or WHtR (OR=1.75); and hypertriglyceridemia was 
more closely associated with WC (OR=1.91) than BMI (OR=1.79) or WHtR (OR=1.87). In women, three 
adiposity measurements had similar association with metabolic abnormalities. 
Conclusions: Simple anthropometric measurements can be used to screen high-risk individuals of 
metabolic abnormalities in Korean men and women, although certain obesity indicators are more strongly 
with a specific kind of metabolic abnormality in men.
Keywords: Metabolic abnormalities, Anthropometric measures, Body mass index, Waist circumference, 
Waist-to-height ratio
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Ⅰ. INTRODUCTION
	
	 The	metabolic	syndrome	is	defined	by	a	clustering	
of	multiple	metabolic	abnormalities	including	impaired	
glucose,	insulin	resistance,	high	blood	pressure,	
dyslipidemia	 [1].	 The	 syndrome	 frequently	
accompanies	other	metabolic	abnormalities	such	
as	nonalcoholic	fatty	liver	disease	(NAFLD)	or	
elevated	liver	enzyme	or	chronic	inflammation	
[2-4].	The	rapid	socioeconomic	growth	in	Korea
has	caused	in	lifestyle	changes,	such	as	Westernized	
diet	 and	 sedentary	 behavior,	 which	 have	 led	
to	an	increase	 in	the	prevalence	of	metabolic	
syndrome	from	24.9%	in	1998	to	31.3%	in	2007
[5].	This	increasing	prevalence	is	of	considerable
concern	because	many	studies	show	that	people	
with	the	metabolic	abnormalities	are	at	increased	
risk	for	developing	diabetes	mellitus	and	cardiovascular	
disease	[6,7].
	 Obesity	is	a	strong	risk	factor	for	metabolic	
disorders.	Body	mass	index	(BMI)	is	the	most	
commonly	used	measure	of	obesity,	but	its	relation	
with	abdominal	visceral	fat	is	dependent	on	age	
and	gender	[8].	Ageing	is	associated	with	increase	in	
fat	mass	and	decreases	in	fat-free	mass	even	if	
body	weight	remains	stable	[9].	Moreover,	BMI	
cannot	measure	the	change	of	body	fat	distribution
in	the	elderly.	Therefore,	BMI	is	a	weak	indicator
of	metabolic	abnormalities	[10,11].	Since	many	
studies	 reported	 that	 abdominal	 obesity	 is	
more	 important	to	the	metabolic	abnormalities	
[12-14],	waist	circumference	(WC)	[15-17]	and	
waist-to-height	 ratio	 (WHtR)	 [18-20]	 have
been	suggested	to	measure	abdominal	obesity.
Several	 investigators	have	 concluded	 that	 the	
WC	and	WHtR	are	more	strongly	associated	with	
metabolic	abnormalities	than	BMI	is.	Plenty	of	
data	are	available	on	 the	relationship	between	
obesity	 and	 adverse	 health	 outcomes	 in	 the	
Western	 populations.	 However	 there	 is	 only	
limited	 number	 of	 community-based	 studies
which	examined	the	association	of	anthropometric	
indices	of	obesity	with	metabolic	abnormalities	in	
Koreans.	Therefore,	we	evaluated	the	associations	
between	anthropometric	indices	of	obesity	and	
metabolic	abnormalities	among	community-dwelling	
Korean	adults.	We	additionally	sought	evidence	
as	to	identify	the	best	anthropometric	predictor	
of	the	metabolic	abnormalities.	
Ⅱ. METHODS
A.	Participants
	 This	is	a	cross-sectional	investigation	analyzing
baseline	data	collected	for	a	prospective	community-
based	cohort	study	of	the	Korean	genome	epidemiology	
study	(KoGES).	Subjects	of	the	current	investigation	
were	4,828	people	who	were	enrolled	between	
2008	and	2010,	aged	40-79	years,	and	living	
in	the	community	of	Kangwha	Island,	Incheon,	
South	Korea.	Among	them,	we	excluded	1,104	
participants	who	were	using	antihypertensives,	
antidiabetics,	 or	 lipid	 lowering	 drugs	 and/
or	having	a	history	of	cardiovascular	disease,	
cancer,	 or	 fatty	 liver	 disease.	 Finally,	 3,724	
participants	(1,399	men	and	2,325women)	were	
eligible	for	the	current	analysis.	All	participants	
provided	 written	 informed	 consents,	 and	 the	
study	protocol	was	approved	by	the	Institutional	
Review	Board.
B.	Definition	of	Metabolic	Abnormalities
	 Metabolic	abnormalities	were	defined	as	follows:	1)	
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high	blood	pressure	(systolic	blood	pressure≥140	
mmHg	or	diastolic	blood	pressure	≥90	mmHg)	
[21],	2)	high	fasting	glucose	(≥126	mg/dL)	[22],	
3)	high	 insulin	 resistance	 (homeostasis	model	
assessment	 of	 insulin	 resistance	 ≥2.5)	 [23],	
4)	high	triglycerides	(≥150	mg/dL)	[24],	5)	low	
high-density	lipoprotein	(HDL)	cholesterol	(<40	
mg/dL)	 [24],	 6)	 high	 low-density	 lipoprotein	
(LDL)	 cholesterol	 (≥160	mg/dL)	 [24],	7)	high	
alanine	aminotransferase	(ALT)	(≥43	IU/L),	8)	
high	gamma-glutamyl	 transferase	 (GGT)	 (>50	
IU/L)	[25].	
C.	Measurements
	 Detailed	 methods	 for	 the	 measurements	
were	 previously	 reported	 elsewhere	 [26,27].	
Participants	 were	 individually	 interviewed	 using
standardized	 questionnaires	 to	 obtain	 information	
about	their	general	characteristics,	medical	history,	
medication	use,	and	lifestyle	behaviors,	such	
as	 smoking	 (current	 smokers	 or	 nonsmokers),	
alcohol	 intake	 (current	 alcohol	 drinkers	 or	
nondrinkers),	 and	 level	 of	 exercise	 (regular	
exercise	or	no	exercise).	The	anthropometric	
measurements	 included	 height,	 weight,	 and	
waist	circumference.	We	measured	height	and	
weight	with	subjects	in	light	clothing	and	calculated	
BMI	 by	 dividing	 weight	 by	 height	 (kg/m2).	
Waist	circumference	was	measured	mid-level	
between	 the	 inferior	margin	of	 the	 ribs	and	
the	superior	border	of	iliac	crest	using	a	tape
measure	 (SECA-200;	 SECA,	 Hamburg,	 Germany).	
The	WHtR	was	calculated	as	the	ratio	of	waist	
circumference	and	height.	Resting	blood	pressure	was
measured	twice	by	an	automatic	sphygmomanometer	
(Dinamap	1846	SX/P;	GE	Healthcare,	Waukesha,	
WI,	USA)	with	the	participant	 in	the	sitting	
position	at	least	5	minute	intervals.	If	the	difference	
between	 the	 first	 and	 second	 measurement	
was	more	than	10	mmHg,	a	third	measurement	
was	performed.	The	average	of	 the	 last	 two	
measurements	was	used	for	the	analysis.	Blood	
samples	were	collected	from	the	antecubital	vein	
after	at	least	an	8	hour	fast.	Enzymatic	methods	
were	applied	to	measure	fasting	plasma	glucose,	
triglycerides,	total	cholesterol,	HDL	cholesterol,	
hemoglobin	A1c	 (HbA1c),	 insulin,	 C-reactive	
protein	 (CRP),	 ALT	 and	 GGT	 (ADVIA	 1650;	
Siemens	Healthcare	Diagnostics	Inc.,	Deerfield,	
IL,	USA).	LDL	cholesterol	was	calculated	using	
the	Friedewald’	method	[28].	The	measure	for
insulin	resistance,	the	homeostasis	model	assessment	
of	insulin	resistance	(HOMA-IR),	was	calculated	
as	 fasting	 insulin	 (U/mL)×fasting	 glucose	
(mg/dL)/405	[29].		
D.	Statistical	Analyses
	 Comparison	 between	men	 and	 women	was	
made	using	independent	t-test	and	chi-square	
test.	Since	some	variables	included	in	the	
analysis	were	markedly	skewed,	Spearman
correlation	coefficients	were	used	to	determine	
correlation	between	obesity	indices	and	metabolic	
risk	factors.	Multiple	logistic	regression	analysis	
was	 used	 to	 assess	 the	 odds	 ratio	 for	 the	
individual	 metabolic	 abnormalities	 per	 one	
unit	 increase	 in	 the	measures	of	adiposity.	
Furthermore,	the	receiver	operating	characteristic
(ROC)	 analysis	 was	 used	 to	 compare	 the	
discriminative	power	of	BMI,	WC,	and	WHtR.	
All	statistical	analyses	were	performed	using	
SAS	version	9.2	(SAS	Inc.,	Cary,	NC,	USA).
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Ⅲ. RESULTS
	 General	 characteristics	 for	men	 and	women	
participants	were	shown	in	Table	1.	The	variables	
were	 significantly	 different	 between	 men	 and	
women,	with	the	exception	of	HbA1c	and	CRP.		
	 Men	had	higher	blood	pressure,	triglycerides,	
fasting	glucose	and	liver	enzyme	than	women.
Women	had	higher	BMI,	WC,	WHtR,	total	cholesterol,	
HDL	cholesterol,	LDL	cholesterol,	 insulin	and	
HOMA-IR	than	men.
Table 1. General characteristics and anthropometric measurements
Data are expressed as means ±standard deviation, median [inter quartile range]
BMI: body mass index, WC: waist circumference, WHtR: waist to height ratio,BP: bloodpressure, HDL: high density lipoprotein, LDL: low 
density lipoprotein, CRP: C-reactive protein, HOMA-IR: homeostasis model for insulin resistance, ALT: alanine aminotransferase, GGT: 
gamma-glutamyl transferase
Variables Men (n=1,399) Women (n=2,325) p-value
Age (year) 57.3±8.8 55.2±8.6 <0.001
Height (cm) 165.8±5.9 153.4±5.5 <0.001
Weight (kg) 66.1±9.3 57.9±8.4 <0.001
Measures of adiposity
BMI (kg/㎡) 24.0±2.8 24.6±3.2 <0.001
WC (cm) 85.8±7.5 87.0±8.5 <0.001
WHtR (%) 51.8±4.4 56.8±5.8 <0.001
Lifestyle characteristics
Current smoker (%) 441(31.6) 58(2.5) <0.001
Drinker (%) 1019(72.8) 734(31.6) <0.001
Physical inactivity (%) 908(64.9) 1538(66.2) 0.427
Metabolic risk factors
Systolic BP (mmHg) 121.1±17.2 118.4±18.2 <0.001
Diastolic BP (mmHg) 77.3±10.2 71.7±10.4 <0.001
Total cholesterol (mg/dL) 189.5±32.1 201.0±35.1 <0.001
HDL cholesterol (mg/dL) 42.4±10.4 45.9±10.9 <0.001
LDL cholesterol (mg/dL) 117±30.2 129±31.1 <0.001
Triglycerides (mg/dL) 124[88-185] 114[82-160] <0.001
Fasting glucose (mg/dL) 93[87-102] 90[85-97] <0.001
HbA1c (%) 5.7±0.8 5.7±0.8 0.991
Insulin (uIU/L) 6.2[5.0-7.8] 7[5.6-8.7] <0.001
CRP (mg/L) 0.7[0.4-1.6] 0.7[0.3-1.4] 0.080
HOMA-IR 1.5[1.1-1.9] 1.6[1.2-2.1] <0.001
ALT (IU/L) 23[18-30] 18[15-23] <0.001
GGT (IU/L) 27[18-48] 14[11-20] <0.001
Adiposity indices and metabolic abnormalities
Journal of Health Informatics and Statistics (JHIS), Vol. 39, No. 2, 2014
5
	 Table	2	shows	correlation	coefficients	between	
obesity	 indices	 and	metabolic	 variables,	 after	
adjusting	 for	age,	 smoking,	physical	activity,	
and	alcohol	intake.	BMI,	WC	and	WHtR	are	all	
significantly	 correlated	 with	 blood	 pressure,	
fasting	 glucose,	 HbA1c,	 insulin,	 HOMA-IR,	
triglycerides,	HDL	cholesterol,	CRP,	ALT	and	
GGT	 in	 both	 sexes.	However,	 the	 correlation	
between	 obesity	 indices	 and	 LDL	 cholesterol,	
was	significantonly	in	women	(p<0.001),	but	not	
in	men	(p=0.435).
*Partial Spearman coefficient adjusted for age, smoking, physical activity, and alcohol intake.
BMI: body mass index, WC: waist circumference, WHtR: waist to height ratio, BP: blood pressure, HDL: high density lipoprotein, LDL: 
low density lipoprotein, HOMA-IR: homeostasis model for insulin resistance, CRP: C-reactive protein, ALT: alanine aminotransferase, GGT: 
gamma-glutamyl transferase
Variables
BMI WC WHtR
r* p-value r* p-value r* p-value
Men (n=1,399)
Systolic BP (mmHg) 0.22 <0.001 0.22 <0.001 0.23 <0.001
Diastolic BP(mmHg) 0.18 <0.001 0.20 <0.001 0.19 <0.001
Fasting glucose (mg/dL) 0.22 <0.001 0.23 <0.001 0.24 <0.001
HbA1c (%) 0.21 <0.001 0.19 <0.001 0.21 <0.001
Insulin (uIU/L) 0.47 <0.001 0.47 <0.001 0.46 <0.001
HOMA-IR 0.47 <0.001 0.48 <0.001 0.47 <0.001
Triglycerides (mg/dL) 0.34 <0.001 0.37 <0.001 0.36 <0.001
HDL cholesterol (mg/dL) -0.29 <0.001 -0.27 <0.001 -0.27 <0.001
LDL cholesterol (mg/dL) 0.02 0.435 0.02 0.414 0.02 0.414
CRP (mg/L) 0.23 <0.001 0.26 <0.001 0.27 <0.001
ALT (IU/L) 0.26 <0.001 0.26 <0.001 0.27 <0.001
GGT (IU/L) 0.26 <0.001 0.28 <0.001 0.29 <0.001
Women (n=2,325)
Systolic BP (mmHg) 0.26 <0.001 0.23 <0.001 0.24 <0.001
Diastolic BP (mmHg) 0.22 <0.001 0.18 <0.001 0.18 <0.001
Fasting glucose (mg/dL) 0.20 <0.001 0.19 <0.001 0.19 <0.001
HbA1c (%) 0.22 <0.001 0.24 <0.001 0.25 <0.001
Insulin (uIU/L) 0.37 <0.001 0.33 <0.001 0.32 <0.001
HOMA-IR 0.38 <0.001 0.34 <0.001 0.33 <0.001
Triglycerides (mg/dL) 0.24 <0.001 0.23 <0.001 0.23 <0.001
HDL cholesterol (mg/dL) -0.13 <0.001 -0.11 <0.001 -0.10 <0.001
LDL cholesterol (mg/dL) 0.09 <0.001 0.10 <0.001 0.10 <0.001
CRP (mg/L) 0.35 <0.001 0.33 <0.001 0.34 <0.001
ALT (IU/L) 0.25 <0.001 0.22 <0.001 0.24 <0.001
GGT (IU/L) 0.29 <0.001 0.26 <0.001 0.28 <0.001
Table 2. Correlation between anthropometric obesity indices and metabolic variables
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Table 3. Association with anthropometric obesity indices and metabolic abnormalities
Adjustment for age, smoking, physical activity, and alcohol intake.
1)high blood pressure (a systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg [21], 2)high fasting glucose (≥126 mg/dL) 
[22], 3)high insulin resistance (deﬁned as HOMA-IR ≥2.5) [23], 4)high triglycerides (≥150 mg/dL) [24], 5)low HDL cholesterol (<40 mg/dL) [24], 
6)high LDL cholesterol (≥160 mg/dL) [24], 7)high ALT (≥43 IU/L), 8)high GGT (>50 IU/L) [25]
BMI: body mass index, WC: waist circumference, WHtR: waist to height ratio, HDL: high density lipoprotein, LDL: low density lipoprotein, 
HOMA-IR: homeostasis model for insulin resistance, ALT: alanine aminotransferase, GGT: gamma-glutamyl transferase
Metabolic abnormalities
Odds ratio (95% confidence interval) per 1-SD increase in
BMI WC WHtR
Men (n=1,399)
High blood pressure1) 1.58 (1.29, 1.93) 1.40 (1.14, 1.71) 1.44 (1.17, 1.76)
High glucose2) 1.44 (1.14, 1.84) 1.79 (1.40, 2.30) 1.75 (1.37, 2.24)
High HOMA-IR3) 2.54 (2.10, 3.07) 2.55 (2.11, 3.08) 2.44 (2.02, 2.95)
High triglycerides4) 1.79 (1.58, 2.03) 1.91 (1.68, 2.17) 1.87 (1.64, 2.12)
Low HDL cholesterol5) 1.68 (1.50, 1.90) 1.64 (1.46, 1.84) 1.63 (1.45, 1.83)
High LDL cholesterol6) 1.03 (0.85, 1.26) 1.15 (0.95, 1.39) 1.17 (0.97, 1.42)
High ALT7) 1.70 (1.41, 2.07) 1.64 (1.35, 1.99) 1.74 (1.43, 2.12)
High GGT8) 1.43 (1.24, 1.63) 1.48 (1.29, 1.70) 1.51 (1.31, 1.73)
Women (n=2,325)
High blood pressure1) 1.32 (1.09, 1.61) 1.34 (1.08, 1.68) 1.29 (1.02, 1.62)
High glucose2) 1.98 (1.65, 2.38) 2.01 (1.61, 2.51) 1.92 (1.52, 2.42)
High HOMA-IR3) 2.25 (1.99, 2.55) 2.28 (1.99, 2.60) 2.20 (1.92, 2.52)
High triglycerides4) 1.47 (1.34, 1.61) 1.55 (1.40, 1.70) 1.56 (1.41, 1.72)
Low HDL cholesterol5) 1.24 (1.13, 1.35) 1.19 (1.09, 1.30) 1.17 (1.06, 1.28)
High LDL cholesterol6) 1.17 (1.05, 1.30) 1.23 (1.09, 1.37) 1.23 (1.09, 1.39)
High ALT7) 1.82 (1.51, 2.18) 1.89 (1.52, 2.36) 2.01 (1.60, 2.53)
High GGT8) 1.72 (1.46, 2.04) 1.74 (1.42, 2.12) 1.86 (1.51, 2.30)
	 Table	3	shows	the	odds	ratio	for	each	metabolic	
abnormality	associated	with	one	unit	increase	in	
the	adiposity	measurements,	after	adjusting	for	
age,	smoking,	physical	activity,	and	alcohol	intake.	
The	 adiposity	 measurements	 were	 associated	
with	all	of	the	metabolic	abnormalities.	Exceptionally,	
high	LDL	cholesterol	level	in	men	was	not	associated	
with	any	of	obesity	measures.	In	male	subjects,	
among	the	three	adiposity	measurements,	BMI	
was	most	 strongly	 associated	with	high	 blood	
pressure	(OR:	1.58,	95%	CI:	1.29-1.93)	WC	was	
most	strongly	associated	with	high	fasting	glucose
(OR:	1.79,	95%	CI:	1.40-2.30)	and	high	triglycerides
(OR:	1.91,	95%	CI:	1.68-2.17).	However,	in	women,	
all	three	adiposity	measures	showed	similar	magnitude	
of	associations	with	metabolic	abnormalities.	
Adiposity indices and metabolic abnormalities
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Table 4. Receiver operating characteristic curve of anthropometric obesity indices and metabolic abnormalities
1)high blood pressure (a systolic blood pressure ≥140 mmHg or diastolic blood pressure ≥90 mmHg [21], 2)high fasting glucose (≥126 mg/dL) 
[22], 3)high insulin resistance (deﬁned as HOMA-IR ≥2.5) [23], 4)high triglycerides (≥150 mg/dL) [24], 5)low HDL cholesterol (<40 mg/dL) [24], 
6)high LDL cholesterol (≥160 mg/dL) [24], 7)high ALT (≥43 IU/L), 8)high GGT (>50 IU/L) [25]
AUC: area under the receiver operating characteristic curve, CI: confidence interval, BMI: body mass index, WC: waist circumference, WHtR: 
waist to height ratio, HDL: high density lipoprotein, LDL: low density lipoprotein, HOMA-IR: homeostasis model for insulin resistance, ALT: 
alanine aminotransferase, GGT: gamma-glutamyl transferase
Metabolic abnormalities
BMI WC WHtR
AUC (95% CI) AUC (95% CI) AUC (95% CI)
Men (n=1,399)
High blood pressure1) 0.633 (0.58, 0.69) 0.608 (0.55, 0.67) 0.603 (0.55, 0.66)
High glucose2) 0.603 (0.54, 0.67) 0.654 (0.59, 0.72) 0.654 (0.59, 0.72)
High HOMA-IR3) 0.735 (0.69, 0.78) 0.736 (0.70, 0.78) 0.715 (0.67, 0.76)
High triglycerides4) 0.642 (0.61, 0.67) 0.627 (0.60, 0.66) 0.624 (0.60, 0.65)
Low HDL cholesterol5) 0.655 (0.63, 0.68) 0.669 (0.64, 0.70) 0.651 (0.62, 0.68)
High LDL cholesterol6) 0.507 (0.45, 0.56) 0.533 (0.48, 0.59) 0.530 (0.48, 0.59)
High ALT7) 0.643 (0.59, 0.70) 0.653 (0.60, 0.71) 0.642 (0.59, 0.69)
High GGT8) 0.598 (0.56, 0.63) 0.617 (0.58, 0.65) 0.601 (0.57, 0.64)
Women (n=2,325)
High blood pressure1) 0.583 (0.51, 0.66) 0.572 (0.50, 0.65) 0.543 (0.49, 0.60)
High glucose2) 0.692 (0.60, 0.78) 0.679 (0.60, 0.76) 0.675 (0.61, 0.74)
High HOMA-IR3) 0.722 (0.67, 0.78) 0.710 (0.66, 0.76) 0.697 (0.67, 0.73)
High triglycerides4) 0.619 (0.58, 0.66) 0.634 (0.60, 0.67) 0.643 (0.62, 0.67)
Low HDL cholesterol5) 0.566 (0.53, 0.60) 0.562 (0.53, 0.60) 0.562 (0.54, 0.59)
High LDL cholesterol6) 0.552 (0.48, 0.63) 0.571 (0.51, 0.63) 0.573 (0.54, 0.61)
High ALT7) 0.655 (0.59, 0.73) 0.664 (0.60, 0.73) 0.672 (0.61, 0.73)
High GGT8) 0.656 (0.61, 0.70) 0.646 (0.60, 0.69) 0.654 (0.60, 0.71)
the	AUC	of	BMI	was	greater	than	that	of	WC	or	
WHtR	in	the	prediction	of	high	blood	pressure,	
high	fasting	glucose,	high	HOMA-IR,	low	HDL	
cholesterol,	and	high	GGT	the	AUC	of	WHtR	was	
greater	than	that	of	BMI	or	WC	in	the	prediction	
of	high	triglycerides,	high	LDL	cholesterol,	and	
high	ALT.
	 The	area	under	the	curve	(AUC)	of	the	three	
anthropometric	indices	in	the	prediction	of	metabolic
abnormalities	 are	 shown	 in	 Table	 4.	 In	 men,	
the	AUC	of	WC	was	greater	than	that	of	BMI	or	
WHtR	in	the	prediction	of	high	fasting	glucose,	
high	HOMA-IR,	low	HDL	cholesterol,	high	LDL	
cholesterol,	high	ALT,	and	high	GGT.	In	women,	
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Ⅳ. DISCUSSION
	 This	study	showed	strong	associations	between	
anthropometric	 measures	 and	 metabolic
abnormalities	 in	 apparently	 healthy	Korean	
adults.	In	male	adults,	BMI	was	more	closely	
association	with	high	blood	pressure,	while	
WC	 was	 more	 closely	 associated	 with	 high	
glucose	 and	 triglycerides.	 On	 the	 basis	 of	
discriminative	 power,	 BMI	 and	 WHtR	 were	
better	predictors	of	metabolic	abnormalities	
than	WC	in	female,	whereas	WC	is	the	best	
predictor	in	male.	Among	various	measurements	
of	obesity,	BMI	is	the	most	frequently	used	in	
epidemiologic	and	clinical	studies.	However,	
BMI	is	not	a	good	measure	of	visceral	fat,	the	
key	determinant	of	metabolic	abnormalities.	Some	
authors	have	reported	that	WC	and	WHtR	are	
better	at	predicting	metabolic	risk	factors	[30-
32].	Compared	to	BMI,	WC	is	more	sensitive	
because	increase	of	muscle	mass	might	lead	
to	little	change	of	BMI	but	apparent	changes	
in	WC	and	WHtR.	In	the	practice,	WC	can	be	
a	more	convenient	measure	than	WHtR,	since	
ratios	generally	have	larger	measurement	error	
than	both	their	numerators	and	denominators	
[33-35].	On	 the	 other	hand,	WHtR	 can	be	
used	widely	from	children	to	adults	with	support	of	
consumer-friendly	conversion	charts,	but	WC	
may	not	suit	all	groups	and	does	not	reflect	
body	stature	[36].	Some	studies	reported	that	
WHtR	 correlates	 better	with	 body	 fat	mass	
than	WC	does	[37].These	results	suggest	that	BMI,	
WC,	and	WHtR	may	have	different	associations	
with	metabolic	abnormalities.
	 In	our	analysis,	all	of	BMI,	WC	and	WHtR	
showed	 strong	 associations	 with	 metabolic	
abnormalities,	although	certain	obesity	indicators	
are	more	strongly	with	a	specific	kind	of	metabolic	
abnormality	in	male	adults.	More	specifically,	
high	blood	pressure	was	more	strongly	associated	
with	BMI,	and	high	fasting	glucose	and	triglycerides	
levels	were	more	closely	associated	with	WC.	In	
addition,	we	used	ROC	analysis	to	address	the	
issue	of	discriminative	performance.	WC	seems	
to	be	a	better	predictor	of	metabolic	abnormality	
in	men,	while	BMI	and	WHtR	seem	to	be	better	
than	BMI	 in	women.	However,	 the	difference
in	the	magnitude	of	association	and	discriminative	
power	was	not	big	enough	to	choose	the	single	
best	 index.	 Our	 findings	 are	 only	 in	 partial	
agreement	with	the	observation	that	specific	simple	
anthropometric	index	is	helpful	for	predicting	
the	metabolic	 abnormalities	 in	 Korean	 adults	
[38,39].	We	would	like	to	recommend	measuring	
BMI,	WC	and	WHtR	in	health	screenings,	because	
all	 the	 three	 indices	 can	 be	 easily	measured	
together	and	we	can	predict	better	a	specific	
component	of	metabolic	abnormalities	by	measuring	
three	indices.
	 This	study	has	the	following	limitations.	First,	
the	current	study	had	no	data	directly	assessing	
deposition	 of	 central	 fat	 such	 as	 dual	 X-ray	
absorptiometry	body	composition	analysis.	Thus,	
we	could	not	address	the	relationship	between	
direct	measures	of	regional	fat	distribution	
and	metabolic	abnormalities.	Second,	our	analysis	
was	based	on	a	 cohort	 study	 from	one	 rural	
area	and	limited	to	relatively	healthy	individuals.	
Thus,	these	results	cannot	be	generalized	for	
the	entire	Korean	adult	population.	Third,	this	
is	 a	 cross-sectional	 analysis.	We	 could	 not	
determine	whether	the	anthropometric	measures	
predict	change	in	metabolic	profile	or	onset	of	new	
Adiposity indices and metabolic abnormalities
Journal of Health Informatics and Statistics (JHIS), Vol. 39, No. 2, 2014
9
metabolic	abnormalities.
	 Since	 metabolic	 syndrome	 or	 its	 individual	
metabolic	abnormalities	predict	 future	 risk	of	
cardiovascular	disease	 [40,41],	 our	 study	
underscores	 the	 potential	 importance	 of	
reduction	of	adiposity	for	prevention	of	metabolic	
abnormalities	 and	 cardiovascular	 disease.	 In	
addition	we	support	that	anthropometric	obesity	
measures,	which	are	simple,	inexpensive,	reliable,	
and	suitable	 for	various	settings,	 can	predict	
metabolic	abnormalities	instead	of	using	restricted	
mobility	and	expensive	equipment.
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